Equillium Stock Performance

EQ Stock  USD 1.55  0.01  0.64%   
The firm shows a Beta (market volatility) of 2.75, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Equillium will likely underperform. Equillium has an expected return of -0.56%. Please make sure to confirm Equillium total risk alpha, daily balance of power, as well as the relationship between the Daily Balance Of Power and period momentum indicator , to decide if Equillium performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Equillium has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in June 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors. ...more
1
Acquisition by Joel Rothman of 8804 shares of Equillium subject to Rule 16b-3
02/26/2024
2
Equillium Inc Announces New Principal Accounting Officer and 2024 Inducement Plan - TipRanks.com - TipRanks
03/08/2024
3
Little Excitement Around Equillium, Inc.s Revenues
03/27/2024
4
Equillium reports promising lupus treatment results in study
04/01/2024
5
Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635
04/03/2024
6
Acquisition by Zedelmayer Christine of 8334 shares of Equillium at 2.45 subject to Rule 16b-3
04/12/2024
7
EQ Inc. Reports Profitable Fourth Quarter and 2023 Year End Financial Results
04/15/2024
8
Disposition of 8490 shares by Stephen Connelly of Equillium at 7.0842 subject to Rule 16b-3
04/23/2024
9
10 Effective Ways Leaders Can Improve Their Emotional Intelligence
04/25/2024
10
Were Keeping An Eye On Equilliums Cash Burn Rate
05/02/2024
11
Equillium GAAP EPS of -0.08, revenue of 10.7M
05/09/2024
12
Insider Trading
05/13/2024
13
Markets EQ Unveils Strategic Purchase of Voice AI Trailblazer Helios Life Enterprises
05/20/2024
Begin Period Cash Flow59.1 M
  

Equillium Relative Risk vs. Return Landscape

If you would invest  250.00  in Equillium on February 21, 2024 and sell it today you would lose (95.00) from holding Equillium or give up 38.0% of portfolio value over 90 days. Equillium is generating negative expected returns and assumes 6.3142% volatility on return distribution over the 90 days horizon. Put differently, 55% of stocks are less risky than Equillium on the basis of their historical return distribution, and some 99% of all equities are expected to be superior in generating returns on investments over the next 90 days.
  Expected Return   
       Risk  
Allowing for the 90-day total investment horizon Equillium is expected to under-perform the market. In addition to that, the company is 10.83 times more volatile than its market benchmark. It trades about -0.09 of its total potential returns per unit of risk. The NYSE Composite is currently generating roughly 0.15 per unit of volatility.

Equillium Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Equillium's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Equillium, and traders can use it to determine the average amount a Equillium's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.0884

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsEQ

Estimated Market Risk

 6.31
  actual daily
55
55% of assets are less volatile

Expected Return

 -0.56
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.09
  actual daily
0
Most of other assets perform better
Based on monthly moving average Equillium is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Equillium by adding Equillium to a well-diversified portfolio.

Equillium Fundamentals Growth

Equillium Stock prices reflect investors' perceptions of the future prospects and financial health of Equillium, and Equillium fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Equillium Stock performance.

About Equillium Performance

To evaluate Equillium Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Equillium generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Equillium Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Equillium market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Equillium's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 0.00  0.00 
Return On Tangible Assets(0.26)(0.28)
Return On Capital Employed(0.63)(0.66)
Return On Assets(0.26)(0.28)
Return On Equity(0.59)(0.62)

Things to note about Equillium performance evaluation

Checking the ongoing alerts about Equillium for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Equillium help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Equillium generated a negative expected return over the last 90 days
Equillium has high historical volatility and very poor performance
Equillium may become a speculative penny stock
The company generated the yearly revenue of 36.08 M. Annual Net Loss to common stockholders was (13.34 M) with gross profit of 15.76 M.
Equillium reports about 57.56 M in cash with (21.78 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.68, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Equillium has a very weak financial position based on the latest SEC disclosures
Roughly 36.0% of the company shares are held by company insiders
Latest headline from finance.yahoo.com: Markets EQ Unveils Strategic Purchase of Voice AI Trailblazer Helios Life Enterprises
Evaluating Equillium's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Equillium's stock performance include:
  • Analyzing Equillium's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Equillium's stock is overvalued or undervalued compared to its peers.
  • Examining Equillium's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Equillium's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Equillium's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Equillium's stock. These opinions can provide insight into Equillium's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Equillium's stock performance is not an exact science, and many factors can impact Equillium's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
When determining whether Equillium is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Equillium Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Equillium Stock. Highlighted below are key reports to facilitate an investment decision about Equillium Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Equillium. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in producer price index.
To learn how to invest in Equillium Stock, please use our How to Invest in Equillium guide.
You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Complementary Tools for Equillium Stock analysis

When running Equillium's price analysis, check to measure Equillium's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Equillium is operating at the current time. Most of Equillium's value examination focuses on studying past and present price action to predict the probability of Equillium's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Equillium's price. Additionally, you may evaluate how the addition of Equillium to your portfolios can decrease your overall portfolio volatility.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Is Equillium's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Equillium. If investors know Equillium will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Equillium listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.35)
Revenue Per Share
1.085
Quarterly Revenue Growth
0.204
Return On Assets
(0.14)
Return On Equity
(0.48)
The market value of Equillium is measured differently than its book value, which is the value of Equillium that is recorded on the company's balance sheet. Investors also form their own opinion of Equillium's value that differs from its market value or its book value, called intrinsic value, which is Equillium's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Equillium's market value can be influenced by many factors that don't directly affect Equillium's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Equillium's value and its price as these two are different measures arrived at by different means. Investors typically determine if Equillium is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Equillium's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.